Cargando…

Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation

Autologous haematopoietic stem cell transplantation (AHSCT) is a therapeutic option for haematological malignancies, such as non-Hodgkin’s lymphoma (NHL), and more recently, for autoimmune diseases, such as treatment-refractory multiple sclerosis (MS). The immunological mechanisms underlying remissi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hendrawan, Kevin, Khoo, Melissa L. M., Visweswaran, Malini, Massey, Jennifer C., Withers, Barbara, Sutton, Ian, Ma, David D. F., Moore, John J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807525/ https://www.ncbi.nlm.nih.gov/pubmed/35126353 http://dx.doi.org/10.3389/fimmu.2021.782935

Ejemplares similares

Sustained immunotolerance in multiple sclerosis after stem cell transplant
por: Visweswaran, Malini, et al.
Publicado: (2022)

Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis
por: Massey, Jennifer, et al.
Publicado: (2022)

Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant
por: Massey, Jennifer C., et al.
Publicado: (2018)

Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosis
por: Burman, Joachim, et al.
Publicado: (2023)

The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis
por: Willison, A. G., et al.
Publicado: (2022)

Second autologous haematopoietic stem cell transplantation in systemic sclerosis—a case report
por: van Rhijn-Brouwer, Femke C C, et al.
Publicado: (2019)

Autologous Haematopoietic Stem Cell Transplantation and Systemic Sclerosis: Focus on Interstitial Lung Disease
por: Bagnato, Gianluca, et al.
Publicado: (2022)

Correction to: The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis
por: Willison, A. G., et al.
Publicado: (2022)

Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline
por: Bayas, Antonios, et al.
Publicado: (2023)

Autologous haematopoietic stem cell transplantation for neurological diseases
por: Burman, Joachim, et al.
Publicado: (2018)

Chronic inflammatory demyelinating polyradiculoneuropathy occurring after autologous haematopoietic stem cell transplantation for multiple sclerosis
por: Simonsen, Cecilia Smith, et al.
Publicado: (2016)

Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing–remitting multiple sclerosis: an observational study
por: Zhukovsky, Christina, et al.
Publicado: (2021)

Autologous haematopoietic stem cell transplantation versus low‐dose immunosuppression in secondary–progressive multiple sclerosis
por: Mariottini, Alice, et al.
Publicado: (2022)

Haematopoietic stem cell transplantation in systemic sclerosis
por: Walker, Ulrich A, et al.
Publicado: (2018)

Autologous Haematopoietic Stem Cell Transplantation in Multiple Sclerosis: a Review of Current Literature and Future Directions for Transplant Haematologists and Oncologists
por: Das, Joyutpal, et al.
Publicado: (2019)

Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with ‘aggressive’ multiple sclerosis
por: Das, J, et al.
Publicado: (2021)

Changes on chest HRCT in systemic sclerosis-related interstitial lung disease after autologous haematopoietic stem cell transplantation
por: Pugnet, Grégory, et al.
Publicado: (2022)

Anti-thymocyte globulin exposure in patients with diffuse cutaneous systemic sclerosis undergoing autologous haematopoietic stem cell transplantation
por: Chiu, Yu-Hsiang, et al.
Publicado: (2023)

Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone
Publicado: (1996)

A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper
por: Saccardi, R, et al.
Publicado: (2012)

Cytokine Signature in Schnitzler Syndrome: Proinflammatory Cytokine Production Associated to Th Suppression
por: Masson Regnault, Marie, et al.
Publicado: (2020)

Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis
por: Adamska, Julia Z, et al.
Publicado: (2023)

Recapitulative haematopoietic development of human pluripotent stem cells in the absence of exogenous haematopoietic cytokines
por: Philonenko, Elena S., et al.
Publicado: (2021)

Elevated Levels of Proinflammatory Cytokines in Cerebrospinal Fluid of Multiple Sclerosis Patients
por: Khaibullin, Timur, et al.
Publicado: (2017)

Autologous haematopoietic stem cell therapy for multiple sclerosis: a review for supportive care clinicians on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation
por: Ismail, Azza, et al.
Publicado: (2019)

Autologous haematopoietic stem cell transplantation for refractory stiff-person syndrome: the UK experience
por: Kass-Iliyya, Lewis, et al.
Publicado: (2020)

Proinflammatory Cytokines in Peritonitis
por: Badiu, DC, et al.
Publicado: (2011)

Relationships of growth factors, proinflammatory cytokines, and anti-inflammatory cytokines with long-term clinical results of autologous bone marrow mononuclear cell transplantation in STEMI
por: Ryabov, Vyacheslav V., et al.
Publicado: (2017)

Haematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis: Recent Advances
por: Mariottini, Alice, et al.
Publicado: (2023)

Abnormal body composition is a predictor of adverse outcomes after autologous haematopoietic cell transplantation
por: Armenian, Saro H., et al.
Publicado: (2020)

Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
por: Kobayashi, Eri H., et al.
Publicado: (2016)

The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2015)

Differential cytokine contributions of perivascular haematopoietic stem cell niches
por: Asada, Noboru, et al.
Publicado: (2017)

Inhibitory KIR–HLA receptor–ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma
por: Leung, W, et al.
Publicado: (2007)

PB2193: IS HYPERHYDRATION NECESSARY FOR HIGH DOSE MELPHALAN CONDITIONING REGIMEN IN AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION?
por: Mora Argumánez, M., et al.
Publicado: (2022)

Berberine protects against esophageal mucosal damage in reflux esophagitis by suppressing proinflammatory cytokines
por: CHOO, BYUNG KIL, et al.
Publicado: (2013)

(+)-Borneol is neuroprotective against permanent cerebral ischemia in rats by suppressing production of proinflammatory cytokines
por: Chang, Lei, et al.
Publicado: (2017)

PHLDA1 Suppresses TLR4-Triggered Proinflammatory Cytokine Production by Interaction With Tollip
por: Peng, Hui, et al.
Publicado: (2022)

Acidic Cannabinoids Suppress Proinflammatory Cytokine Release by Blocking Store-operated Calcium Entry
por: Faouzi, Malika, et al.
Publicado: (2022)

Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation
por: Ayoglu, Burcu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lrg0t0a34qvol0fcon0lqptiph